PubMed Health⌕ Search

PubMed · 2672190

[Chronic functional dyspepsia or irritable colon].

Abstract

An attempt is made to synthesize the fundamental information concerning the pathogenesis of chronic functional digestive disorders, which should be designated as "chronic functional dyspepsia". At present the term "irritable colon" does not seem justified since the disorder affects the entire gastrointestinal tract. In the development of this disorder three types of fundamental pathogenic factors apparently participate: 1. Deficient protein nutrition leading to hypotrophy of the intestinal mucosa. 2. Alterations of intestinal motility related fundamentally to neurotic dysfunction. These are hyperreactive phenomena by the smooth muscle in response to normal stimuli on a background of generalized gastrointestinal hypotonia. They seem to be due to an excess of certain neurotransmitters, principally dopamine, at the level of the myenteric plexus. 3. Infectious factors of the infectious Crohn type provoked by intestinal bacterial overgrowth. These derive from motility alterations, with stasis or delayed transit, and hypotrophy due to deficient nutrition that alters the intraluminal ecological medium. This alteration impairs the development of the normal saprophytic flora and facilitates the proliferation of anaerobic colonic germs, leading to intestinal bacterial overgrowth.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A Fernández Ibáñez, P Fernández Orcajo. 1989. [Chronic functional dyspepsia or irritable colon].. https://pubmed.ncbi.nlm.nih.gov/2672190/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Pharmacological treatment of the irritable bowel syndrome and other functional bowel disorders.

Functional digestive disorders constitute one of the main causes of consultation in gastroenterology and primary health care. Is still unclear whether therapy has to be aimed to the gut, to the neural pathways controlling bowel motility and perception, or to the processing mechanisms of symptoms and disease behaviour. It is conceivable that in the next future better understanding of functional bowel disorders pathophysiology will help us to tailor treatment for different patients. At the moment, subclassification of the diverse patterns of symptomatology allows to adjust new treatments for irritable bowel syndrome (IBS) according to the clinical predominance for each patient. The knowledge of motor and sensorial response to different stimuli in IBS patients and the pathways to the central nervous system is an important source of information for the development of new molecules. Fiber-enriched diet is frequently given for constipation-predominant IBS. Loperamide, antispasmodic drugs and tricyclic antidepressants are nowadays the basis for pharmacological treatment of diarrhea- predominant IBS. The scientific evidence supporting this therapeutical approach is however limited. Visceral analgesics and serotonin agonists and antagonists may play an important therapeutical role in the near future. However, it is not likely that one single treatment will help every functional bowel disorder patient and many of them will need a more complex approach with a multidisciplinary therapy (diet, psychotherapy, medications).

Colonic Diseases, Functional↗

Hypnotherapy for functional gastrointestinal disorders.

About 20% of people in the UK have functional gastrointestinal disorders such as irritable bowel syndrome and functional dyspepsia. These conditions account for about 4% of GP consultations and 50% of gastroenterologists' workload. Forsome, the symptoms affect quality of life and ability to work. Drug treatment aimed at relieving symptoms is often ineffective. Other options include psychological treatments such as cognitive behavioural therapy, brief psychotherapy and gut-directed hypnotherapy. Here we discuss whether hypnotherapy has a role in the treatment of patients with irritable bowel syndrome or functional dyspepsia.

Colonic Diseases, Functional↗